Placebo analgesia and the heart

Pain

Volumn 102, Issue 1-2, 2003, Pages 125-133

  Pollo, Antonella ^a   Vighetti, Sergio ^a   Rainero, Innocenzo ^a,b   Benedetti, Fabrizio ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Department of Neuroscience   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Analgesia; Expectation; Heart rate; Muscarinic receptors; Opioid systems; Pain; Placebo; adrenoreceptors

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC AGENT; NALOXONE; PLACEBO; PROPRANOLOL;

ADRENERGIC SYSTEM; ADULT; ANALGESIA; ARTICLE; BRADYCARDIA; CARDIOVASCULAR SYSTEM; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; EXPERIMENTAL TEST; FEMALE; HEART; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; LABORATORY; MALE; PRIORITY JOURNAL; SPECTROSCOPY; STIMULUS RESPONSE;

EID: 0037333253     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0304-3959(02)00345-7     Document Type: Article

References (32)

1. Amanzio M., Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific sub-systems. J Neurosci. 19:1999;484-494.
2. Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 90:2001;205-215.
3. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 64:1996;535-543.
4. Benedetti F., Amanzio M. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog Neurobiol. 52:1997;109-125.
5. Benedetti F., Amanzio M., Baldi S., Casadio C., Maggi G. Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci. 11:1999;625-631.
6. Benedetti F., Arduino C., Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci. 19:1999;3639-3648.
7. Bouloux P.M., Grossman A., Al-Damluji S., Bailey T., Besser M. Enhancement of the sympathoadrenal response to the cold-pressor test by naloxone in man. Clin Sci (Lond). 69:1985;365-368.
8. Fields H.L., Price D.D. Toward a neurobiology of placebo analgesia. Harrington A. The placebo effect: an interdisciplinary exploration. 1997;93-116 Harvard University Press, Cambridge, MA.
9. Fontana F., Bernardi P., Pich E.M., Boschi S., De Iasio R., Spampinato S., Grossi G. Opioid peptide modulation of circulatory and endocrine response to mental stress in humans. Peptides. 8:1997;169-175.
10. Grevert P., Albert L.H., Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain. 16:1983;129-143.
11. Haddad G.G., Jeng H.J., Lai T.L. Effect of endorphins on heart rate and blood pressure in adult dogs. Am J Physiol. 250:1986;H796-H805.
12. Holaday J.W. Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol. 23:1983;541-594.
13. Holaday J.W. Cardiovascular consequences of endogenous opiate antagonism. Biochem Pharmacol. 32:1983;573-585.
14. Hrobjartsson A., Gotzsche P.C. Is the placebo powerless? N Engl J Med. 344:2001;1594-1602.
15. Hung C.F., Chang W.L., Liang H.C., Su M.J. Identification of opioid receptors in the sympathetic and parasympathetic nerves of guinea-pig atria. Fundam Clin Pharmacol. 14:2000;387-394.
16. Kamath M.V., Fallen E.L. Power spectral analysis of heart rate variability: a non-invasive signature of cardiac autonomic function. Crit Rev Biomed Eng. 21:1993;245-311.
17. Kirsch I. How expectancies shape experience. 1999;American Psychological Association, Washington, DC.
18. Levine J.D., Gordon N.C. Influence of the method of drug administration on analgesic response. Nature. 312:1984;755-756.
19. Levine J.D., Gordon N.C., Fields H.L. The mechanisms of placebo analgesia. Lancet. 2:1978;654-657.
20. Levine J.D., Gordon N.C., Smith R., Fields H.L. Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain. 10:1981;379-389.
21. Malliani A., Pagani M., Lombardi F., Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 84:1991;482-492.
22. McMurray R.G., Newbould E., Bouloux P., Besser G.M., Grossman A. High-dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects. Psychoneuroendocrinology. 16:1991;447-455.
23. Montgomery G., Kirsch I. Mechanisms of placebo pain reduction: an empirical investigation. Psychol Sci. 7:1996;174-176.
24. Morris M., Salmon P., Steiberg H., Sykes E.A., Bouloux P., Newbould E., McLoughlin L., Besser G.M., Grossman A. Endogenous opioids modulate the cardiovascular response to mental stress. Psychoneuroendocrinology. 15:1990;185-192.
25. Musha T., Satoh E., Koyanagawa H., Kimura T., Satoh S. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart. J Pharmacol Exp Ther. 250:1989;1087-1091.
26. Parrat J.R. Opioid receptors in the cardiovascular system. Prog Pharmacol. 6:1986;97-110.
27. Petrovic P., Kalso E., Petersson K.M., Ingvar M. Placebo and opioid analgesia - Imaging a shared neuronal network. Science. 295:2002;1737-1740.
28. Price D.D., Fields H.L. The contribution of desire and expectation to placebo analgesia: implications for new research strategies. Harrington A. The placebo effect: an interdisciplinary exploration. 1997;117-137 Harvard University Press, Cambridge, MA.
29. Price D.D., Milling L.S., Kirsch I., Duff A., Montgomery G.H., Nicholls S.S. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 83:1999;147-156.
30. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. Heart rate variability. Standards of measurements, physiological interpretation, and clinical use. Circulation. 93:1996;1043-1065.
31. Wilson S.P., Klein R.L., Change K.J., Gasparis M.S., Viveros O.H., Young W.H. Are opioid peptides cotransmitters in noradrenergic vesicles of sympathetic nerves? Nature. 288:1980;707-709.
32. Wong-Dusting H.K., Rand M.J. Effect of (D-Ala2, Met5) Enkephalinamide and (D-Ala2, D-Leu5) Enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria. Eur J Pharmacol. 111:1985;65-72.